De Novo and Molecular Target-Independent Discovery of Orally Bioavailable Lead Compounds for Neurological Disorders

E-ISSN： 1875-5828|3|3|205-214

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.3, Iss.3, 2006-07, pp. : 205-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impairment of mitochondrial dynamics: a target for the treatment of neurological disorders?

By Su Yu-Chin Qi Xin

Future Neurology, Vol. 8, Iss. 3, 2013-05 ,pp. : 333-346

Future Medicine

Access to resources Recommend Favorite

Accelerating Discovery for Complex Neurological and Behavioral Disorders Through Systems Genetics and Integrative Genomics in the Laboratory Mouse

By Bubier Jason

Neurotherapeutics, Vol. 9, Iss. 2, 2012-04 ,pp. : 338-348

Springer Publishing Company

Access to resources Recommend Favorite

The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology

By Krizanac-Bengez Ljiljana Mayberg Marc R. Janigro Damir

Neurological Research, Vol. 26, Iss. 8, 2004-12 ,pp. : 846-853

Maney Publishing

Access to resources Recommend Favorite

The effects of anticonvulsant compounds on 4-aminopyridine-induced de novo synthesis of neurotransmitter amino acids in rat hippocampus in vitro

By Kapetanovic I.M. Yonekawa W.D. Kupferberg H.J.

Epilepsy Research, Vol. 20, Iss. 2, 1995-02 ,pp. : 113-120

Elsevier

Access to resources Recommend Favorite

Drug-induced neurological disorders.

By Kapoor R.

Electroencephalography and Clinical Neurophysiology, Vol. 102, Iss. 3, 1997-03 ,pp. : 265-266

Elsevier

Access to resources Recommend Favorite